Lindsay Lehechka
Family · Overland Park, KSNPI 1942833256
Payments from drug & device makers
Across 176 payments — averaging $17.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$951
- Lilly USA, LLC$272
- Novo Nordisk$260
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$171
- Amgen$163
- Boehringer Ingelheim$124
- plus $1K from 30 others
What the payments were for
- Food & beverage$3,149100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 56 | $951 |
| Lilly USA, LLC | 14 | $272 |
| Novo Nordisk | 10 | $260 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 10 | $171 |
| Amgen | 9 | $163 |
| Boehringer Ingelheim | 6 | $124 |
| Otsuka America Pharmaceutical, Inc. | 5 | $116 |
| Corium, LLC | 7 | $115 |
| Biohaven Pharmaceuticals, Inc. | 6 | $113 |
| AstraZeneca | 6 | $91 |
| Merck | 5 | $91 |
| IBSA Pharma Inc. | 3 | $55 |
| Cranial Technologies, Inc | 3 | $51 |
| GSK | 3 | $46 |
| Paratek Pharmaceuticals, Inc. | 3 | $45 |
| Astellas Pharma US Inc | 2 | $38 |
| Eisai Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $33 |
| Dexcom, Inc. | 2 | $31 |
| Forte Bio-pharma LLC | 2 | $31 |
| Pfizer | 2 | $29 |
| Johnson & Johnson | 2 | $26 |
| Currax Pharmaceuticals LLC | 2 | $26 |
| Bayer | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $24 |
| Ascendis Pharma Endocrinology Inc | 1 | $22 |
| Neos Therapeutics, LP | 1 | $21 |
| Sumitomo Pharma America, Inc. | 1 | $20 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Tolmar, Inc. | 1 | $16 |
| Ardelyx, Inc. | 1 | $15 |
| Idorsia Pharmaceuticals US Inc | 1 | $15 |
| Phathom Pharmaceuticals, Inc. | 1 | $15 |
| Novartis | 1 | $15 |
| Corcept Therapeutics | 1 | $15 |
| Organon | 2 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$100
How this compares
$3,149 in reported general payments places this provider in the 90th percentile of 1,579 family providers in Kansas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Citalopram HbrCitalopram Hydrobromide | 14 | $314 |
| Atorvastatin Calcium | 44 | $286 |
| Rosuvastatin Calcium | 40 | $283 |
| Levothyroxine Sodium | 42 | $228 |
| Losartan Potassium | 37 | $213 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 28 | $160 |
| Hydrochlorothiazide | 30 | $104 |
| Lisinopril | 18 | $58 |
| Trazodone Hcl | 19 | $43 |
| Simvastatin | 14 | $36 |
| Amlodipine Besylate | 27 | $29 |
Paid to pharmacies, not to this prescriber.
Other family in Overland Park
- Jennifer ChesterOverland Park$327K
- Erin FeitzOverland Park$36K
- Tracy GraebenerOverland Park$29K
- Kathryn TimmOverland Park$14K
- Lauren BarberOverland Park$12K
- Tracy HillOverland Park$8K
- Matthew NitschOverland Park$7K
- Gretchen PolandOverland Park$7K
- Anaya KoleOverland Park$7K
- Geneva BealOverland Park$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.